HomeRNA • NASDAQ
Avidity Biosciences Inc
add
$29.77
11.33%
After Hours:(4.74%)-1.41
$28.36
Closed: Apr 2, 4:38:21 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 2.97M | 35.57% |
Operating expense | 28.34M | 75.80% |
Net income | -102.26M | -69.18% |
Net profit margin | -3.44K | -24.79% |
Earnings per share | -0.80 | -1.27% |
EBITDA | -120.25M | -81.85% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.50B | 152.20% |
Total assets | 1.56B | 148.81% |
Total liabilities | 138.94M | 8.72% |
Total equity | 1.42B | — |
Shares outstanding | 120.21M | — |
Price to book | 2.25 | — |
Return on assets | -18.88% | — |
Return on capital | -20.56% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -102.26M | -69.18% |
Cash from operations | -99.87M | -705.24% |
Cash from investing | -64.17M | -225.73% |
Cash from financing | 13.72M | -56.97% |
Net change in cash | -150.32M | -251.18% |
Free cash flow | -65.52M | -1,920.70% |
Previous close
$26.74
Day range
$26.27 - $30.64
Year range
$21.56 - $55.98
Market cap
3.58B USD
Avg Volume
1.44M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
CEO
Founded
2012
Website
Employees
391